Katsunori Iwasaki Selected Research

6- (1H- imidazol- 1- yl)- 7- nitro- 2,3(1H,4H)- quinoxalinedione

1/2004

Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsunori Iwasaki Research Topics

Disease

29	Brain Ischemia (Cerebral Ischemia) 03/2018 - 01/2003
19	Ischemia 03/2018 - 12/2002
15	Alzheimer Disease (Alzheimer's Disease) 12/2019 - 12/2002
11	Dementia (Dementias) 03/2018 - 10/2003
8	Infarction (Infarctions) 12/2012 - 10/2004
7	Cerebral Infarction 09/2009 - 01/2003
7	Hypoxia (Hypoxemia) 11/2005 - 10/2002
6	Amyloid Plaque 12/2019 - 05/2005
6	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2018 - 10/2005
6	Memory Disorders (Memory Loss) 08/2012 - 01/2006
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2012 - 12/2002
4	Catalepsy 12/2017 - 11/2006
4	Stroke (Strokes) 12/2012 - 04/2010
3	Cognitive Dysfunction 01/2017 - 01/2006
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2012 - 06/2004
3	Inflammation (Inflammations) 10/2012 - 10/2004
3	Brain Injuries (Brain Injury) 10/2012 - 03/2008
3	Hypothermia 01/2008 - 05/2004
3	Tremor (Tremors) 01/2008 - 01/2006
2	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 03/2010
2	Tuberous Sclerosis (Bourneville's Disease) 04/2015 - 06/2014
2	Transient Ischemic Attack 07/2013 - 03/2013
2	Hypertension (High Blood Pressure) 01/2012 - 09/2010
1	Sleep Wake Disorders 12/2021
1	Hyperalgesia 09/2021
1	Neoplasms (Cancer) 09/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2021
1	Colonic Neoplasms (Colon Cancer) 09/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021
1	Premenstrual Syndrome (Premenstrual Tension) 01/2021
1	Epilepsy (Aura) 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019
1	Anxiety Disorders (Anxiety Disorder) 01/2017
1	Blister (Bulla) 05/2015
1	Intracranial Vasospasm 12/2014
1	Myocardial Infarction 10/2013
1	Fibrosis (Cirrhosis) 10/2013

Drug/Important Bio-Agent (IBA)

10	Neuroprotective AgentsIBA 03/2018 - 10/2003
9	Dronabinol (THC)FDA LinkGeneric 12/2017 - 10/2004
8	Pharmaceutical PreparationsIBA 09/2021 - 03/2005
7	Yi-Gan SanIBA 01/2019 - 03/2009
7	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2018 - 12/2002
7	Amyloid beta-PeptidesIBA 07/2013 - 12/2002
7	CannabidiolIBA 09/2009 - 10/2004
6	Cholinergic Agents (Cholinergics)IBA 07/2013 - 02/2007
6	HMGB1 Protein (HMG1)IBA 10/2012 - 03/2008
3	Amyloid (Amyloid Fibrils)IBA 12/2019 - 01/2012
3	salicylhydroxamic acid (SHAM)IBA 03/2018 - 03/2013
3	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 10/2005
3	Haloperidol (Haldol)FDA LinkGeneric 12/2017 - 10/2005
3	Telmisartan (Micardis)FDA Link 01/2012 - 10/2009
3	Donepezil (Aricept)FDA LinkGeneric 01/2011 - 06/2004
3	Glutamic Acid (Glutamate)FDA Link 04/2010 - 04/2004
3	5-HT1A Serotonin ReceptorIBA 09/2008 - 10/2005
3	theanineIBA 01/2008 - 06/2004
3	OxotremorineIBA 01/2008 - 01/2006
3	Scopolamine (Hyoscine)FDA Link 01/2008 - 01/2005
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 12/2006
2	Proteins (Proteins, Gene)FDA Link 12/2019 - 07/2010
2	trans-sodium crocetinate (crocetin)IBA 04/2015 - 06/2014
2	Dynamin IIBA 07/2013 - 07/2010
2	Protein Isoforms (Isoforms)IBA 12/2012 - 01/2003
2	Peroxidase (Myeloperoxidase)IBA 10/2012 - 12/2008
2	GangliosidesIBA 02/2012 - 02/2003
2	Type 1 Angiotensin ReceptorIBA 01/2012 - 09/2010
2	PPAR gammaIBA 09/2010 - 10/2009
2	SynaptophysinIBA 07/2010 - 04/2010
2	Kangen-karyuIBA 04/2010 - 03/2009
2	Olanzapine (Zyprexa)FDA Link 09/2008 - 02/2008
2	nilvadipine (Escor)IBA 04/2007 - 10/2003
2	Amlodipine (Norvasc)FDA LinkGeneric 04/2007 - 10/2003
2	AMPA Receptors (AMPA Receptor)IBA 01/2007 - 01/2005
2	TAK 147IBA 08/2005 - 06/2004
2	LipopolysaccharidesIBA 03/2005 - 12/2004
2	EnzymesIBA 10/2004 - 12/2002
2	N-Methylaspartate (NMDA)IBA 01/2004 - 12/2002
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2021
1	ibudilastIBA 09/2021
1	Phosphodiesterase InhibitorsIBA 09/2021
1	Nuclear RNAIBA 04/2021
1	Carrier Proteins (Binding Protein)IBA 04/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Plant ExtractsIBA 01/2019
1	yokukansankachimpihangeIBA 01/2019
1	Trifluoperazine (Stelazine)FDA LinkGeneric 01/2018
1	Nerve Growth Factor (NGF)IBA 01/2017
1	hachimijiogan (TJ 7)IBA 01/2017
1	Nerve Growth Factors (Neurotrophins)IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2016
1	TubulinIBA 05/2015
1	GTP Phosphohydrolases (GTPases)IBA 04/2015
1	GTP-Binding Proteins (G-Protein)IBA 04/2015
1	SynteninsIBA 04/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 06/2014

Therapy/Procedure

3	Oral Administration 03/2018 - 04/2010
2	Therapeutics 03/2005 - 10/2004
1	Kampo Medicine (Kampo) 12/2021
1	Homologous Transplantation 10/2013
1	Transplantation 10/2013